Janus Henderson Global Life Sciences Fund Q4 2024 Commentary
The Janus Henderson Global Life Sciences Fund returned -11.16% and the MSCI World Health Care IndexSM returned -11.40%. Click ...
来自MSN2 小时
Has CSL lost its shine as the market's favourite growth story?
CSL shares tumbled 4.95% on the day of its half-year results after revenue, net profits and dividends missed market ...